Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
Abroad (travel likely)RecruitingPHASE2
Conditions
KSHV Inflammatory Cytokine Syndrome (KICS) · Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · NCIMO_referrals@mail.nih.gov · 888-624-1937
Study leads
Ramya M Ramaswami, M.D.
Principal Investigator
National Cancer Institute (NCI)